190 related articles for article (PubMed ID: 3908047)
1. [Immunoserologic differentiation of chronic cholestatic hepatitis. Significance of antimitochondrial antibodies and hepatic membrane antibodies].
Hopf U; Möller B; Lobeck H; Klein R; Berg PA
Dtsch Med Wochenschr; 1985 Dec; 110(50):1924-9. PubMed ID: 3908047
[TBL] [Abstract][Full Text] [Related]
2. [Immunological characteristics of primary biliary cirrhosis patients].
Yan HP; Zhuang H; Liu YM; Feng X; Tan YF; Liu Y; Zhang X; Zhao CH
Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):12-6. PubMed ID: 15670483
[TBL] [Abstract][Full Text] [Related]
3. [The diagnostic value of immunologic findings in the differentiation of chronic liver diseases].
Manns M; Meyer zum Büschenfelde KH; Arnold W
Leber Magen Darm; 1988 Dec; 18(6):290-2, 295, 298 passim. PubMed ID: 3063910
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune liver diseases.
Manns MP; Nakamura RM
Clin Lab Med; 1988 Jun; 8(2):281-301. PubMed ID: 3284697
[TBL] [Abstract][Full Text] [Related]
5. Primary autoimmune cholangitis. An alternative to antimitochondrial antibody-negative primary biliary cirrhosis.
Taylor SL; Dean PJ; Riely CA
Am J Surg Pathol; 1994 Jan; 18(1):91-9. PubMed ID: 8279631
[TBL] [Abstract][Full Text] [Related]
6. Clinical correlation of antimitochondrial antibodies.
Zuber MA; Recktenwald C
Eur J Med Res; 2003 Feb; 8(2):61-70. PubMed ID: 12626283
[TBL] [Abstract][Full Text] [Related]
7. Value of autoantibody analysis in the differential diagnosis of chronic cholestatic liver disease.
Milkiewicz P; Buwaneswaran H; Coltescu C; Shums Z; Norman GL; Heathcote EJ
Clin Gastroenterol Hepatol; 2009 Dec; 7(12):1355-60. PubMed ID: 19631286
[TBL] [Abstract][Full Text] [Related]
8. Clinical diagnosis of primary biliary cirrhosis: a classification based on major and minor criteria.
Taal BG; Schalm SW; ten Kate FW; Hermans J; Geertzen RG; Feltkamp BE
Hepatogastroenterology; 1983 Oct; 30(5):178-82. PubMed ID: 6642402
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of antimitochondrial antibodies].
Rüegg R; Matter L; Schopfer K; Grob PJ
Schweiz Med Wochenschr; 1985 Mar; 115(9):290-6. PubMed ID: 3983600
[TBL] [Abstract][Full Text] [Related]
10. The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome.
Muratori P; Granito A; Pappas G; Pendino GM; Quarneti C; Cicola R; Menichella R; Ferri S; Cassani F; Bianchi FB; Lenzi M; Muratori L
Am J Gastroenterol; 2009 Jun; 104(6):1420-5. PubMed ID: 19491855
[TBL] [Abstract][Full Text] [Related]
11. [Immunology of liver diseases].
Meyer zum Büschenfelde KH
Schweiz Med Wochenschr; 1987 Jul; 117(29):1065-75. PubMed ID: 3313682
[TBL] [Abstract][Full Text] [Related]
12. Serum immunological profile in patients with chronic autoimmune cholestasis.
Romero-Gómez M; Wichmann I; Crespo J; Parés A; Rodrigo L; Alvarez A; Diago M; Pons-Romero F; Sanchez-Munoz D; Aguilar-Reina J; Andrade RJ; Salmeron J; Sánchez-Pobre P; Rebollo JM; Martin-Vivaldi R; Castellano-Megias V; Nuñez-Roldan A; Bruguera M;
Am J Gastroenterol; 2004 Nov; 99(11):2150-7. PubMed ID: 15554996
[TBL] [Abstract][Full Text] [Related]
13. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
[TBL] [Abstract][Full Text] [Related]
14. [Atypical primary biliary cirrhosis or autoimmune cholangitis?].
Primo J; Miralles A; Ferrando J; Albert A; Julve R; Gómez A; García L
Gastroenterol Hepatol; 1999 Dec; 22(10):505-9. PubMed ID: 10650665
[TBL] [Abstract][Full Text] [Related]
15. [The value of antimitochondrial antibody and its subtypes in the diagnosis of primary biliary cirrhosis].
Yao DK; Xie WF; Chen WZ; Liu HY; Tu XQ; Fan LY
Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):9-11. PubMed ID: 15670482
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of serum antimitochondrial antibody-negative primary biliary cirrhosis.
Zhang FK; Jia JD; Wang BE
Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):288-91. PubMed ID: 15138128
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic significance of antimitochondrial antibody profiles A-D in primary biliary cirrhosis].
Klein R; Berg PA
Dtsch Med Wochenschr; 1988 Oct; 113(40):1549-53. PubMed ID: 3168779
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis.
Invernizzi P; Crosignani A; Battezzati PM; Covini G; De Valle G; Larghi A; Zuin M; Podda M
Hepatology; 1997 May; 25(5):1090-5. PubMed ID: 9141422
[TBL] [Abstract][Full Text] [Related]
20. [Presence of SLA/LP autoantibodies in patients with primary biliary cirrhosis as a marker for secondary autoimmune hepatitis (overlap syndrome)].
Kanzler S; Bozkurt S; Herkel J; Galle PR; Dienes HP; Lohse AW
Dtsch Med Wochenschr; 2001 Apr; 126(16):450-6. PubMed ID: 11360449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
